To the top

Page Manager: Webmaster
Last update: 4/19/2017 1:56 PM

Tell a friend about this page
Print version

Magnus Gisslen - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Magnus Gisslen

Professor/ chief physician

Magnus Gisslen
Professor/ chief physician
magnus.gisslen@infect.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Östra sjukhuset , Göteborg


Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 480
405 30 Göteborg
0313421000
Visiting Address: Guldhedsgatan 10 A-B , 413 46 Göteborg

Latest publications

Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.
Albert M Anderson, Kirk A Easley, Nicole Kasher, Donald Franklin, Robert K Heaton et al.
Journal of neurovirology, Journal article 2018
Journal article

Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations 2017
L. Naver, J. Albert, C. Carlander, L. Flamholc, Magnus Gisslén et al.
Infectious Diseases, Journal article 2018
Journal article

Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration
A. Calcagno, C. Pinnetti, A. De Nicolo, E. Scarvaglieri, Magnus Gisslén et al.
British Journal of Clinical Pharmacology, Journal article 2018
Journal article

Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
Erik Sörstedt, C. Carlander, L. Flamholc, B. Hejdeman, V. Svedhem et al.
International Journal of Antimicrobial Agents, Journal article 2018
Journal article

Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden
E. Andersson, A. Nordquist, J. Esbjörnsson, L. Flamholc, Magnus Gisslén et al.
AIDS, Journal article 2018
Journal article

Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
P. D. Burbelo, R. W. Price, Lars Hagberg, H. Hatano, S. Spudich et al.
Journal of Infectious Diseases, Journal article 2018
Journal article

Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
Rosan A Van Zoest, Jonathan Underwood, Davide De Francesco, Caroline A Sabin, James H Cole et al.
The Journal of infectious diseases, Journal article 2018
Journal article

Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.
Michael J Peluso, Victor Valcour, Nittaya Phanuphak, Jintanat Ananworanich, James Lk Fletcsher et al.
AIDS (London, England), Journal article 2017
Journal article

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
Elham Rahimy, Fang-Yong Li, Lars Hagberg, Dietmar Fuchs, Kevin Robertson et al.
The Journal of infectious diseases, Journal article 2017
Journal article

Showing 81 - 90 of 155

2009

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals
Aylin Yilmaz, Arash Izadkhasthi, R. W. Price, PW Mallon, M De Meulder et al.
AIDS Research and Human Retroviruses, Journal article 2009
Journal article

Treatment of HIV infection: Swedish recommendations 2009.
Filip Josephson, Jan Albert, Leo Flamholc, Magnus Gisslén, Olof Karlström et al.
Scandinavian journal of infectious diseases, Review article 2009
Review article

Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.
Ulf Karlsson, Liselotte Antonsson, Johanna Repits, Patrik Medstrand, Christer Owman et al.
AIDS research and human retroviruses, Journal article 2009
Journal article

The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naive HIV-1 infected patients
Filip Josephson, Maria CH Andersson, L. Flamholc, Magnus Gisslén, Lars Hagberg et al.
European Journal Clinical Pharmacology, Journal article 2009
Journal article

Sexuellt överförbara sjukdomar
Magnus Gisslén, G Johannisson, Karin Rignér
Läkemedelsboken 2009/2010, Chapter in book 2009
Chapter in book

2008

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy
Aylin Yilmaz, R. W. Price, S. Spudich, Dietmar Fuchs, Lars Hagberg et al.
Journal of Acquired Immune Deficiency Syndromes, Journal article 2008
Journal article

CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels
F. Josephson, L. Bertilsson, Y. Bottiger, L. Flamholc, Magnus Gisslén et al.
European Journal of Clinical Pharmacology, Journal article 2008
Journal article

Showing 81 - 90 of 155

Page Manager: Webmaster|Last update: 4/19/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?